drugset / Trial / NCT06112353

Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection

NCT06112353

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this research study is to see the outcome of Sugammadex versus Neostigmine with Glycopyrrolate in colorectal surgery as it relates to its effects on post-surgical time (in hours) to first bowel movement and tolerance for solid food (GI-2 recovery) following bowel resection surgery

Timeline

Start
2024-04-17
Primary completion
2026-07
Completion
2026-07-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 0.07 mg/kg
Comparator Sugammadex Other / unclassified 2 mg/kg
Comparator Glycopyrrolate Small molecule 0.014 mg/kg

Indications